Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

ClearPoint Neuro, Inc.

CLPT•NASDAQ
Healthcare
Medical - Devices
$14.76
$0.61(4.31%)
U.S. Market opens in 16h 15m

ClearPoint Neuro, Inc. (CLPT) Stock Overview

Explore ClearPoint Neuro, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap439.1M
P/E Ratio-17.44
EPS (TTM)$-0.83
ROE-1.14%
Fundamental Analysis

AI Price Forecasts

1 Month$7.94
3 Months$11.61
1 Year Target$19.83

CLPT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ClearPoint Neuro, Inc. (CLPT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.83.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.44 and a market capitalization of 439.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.31%
5-Day Change
7.97%
1-Month Change
-5.87%
3-Month Change
6.80%
6-Month Change
37.94%
Year-to-Date (YTD) Change
5.20%
1-Year Change
-9.89%
3-Year Change
72.43%
5-Year Change
-38.91%
All-Time (Max) Change
-50.80%

Contact Information

https://www.clearpointneuro.com
888 287 9109
120 S. Sierra Avenue, Solana Beach, CA, 92075

Company Facts

1,150 Employees
IPO DateMay 22, 2012
CountryUS
Actively Trading

Frequently Asked Questions